Skip to content

Back

FDADrugsRecalled

Houston Rx LLC recalls Tirzepatide/Niacinamide 2mL vial (40 MG per Vial) Inj 20mg/2mg/mL

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Read the official notice on accessdata.fda.gov
What's wrong
Lack of assurance of sterility.
Products
  • Tirzepatide/Niacinamide 2mL vial (40 MG per Vial) Inj 20mg/2mg/mL
Company
Houston Rx LLC
Where it was sold

Nationwide in the USA.

Units affected
64 vials
Status
Ongoing

Recall Relay is not affiliated with or endorsed by FDA or any agency. Details here are copied from the FDA notice and may lag behind it; the official notice is always the final word.